Clinical Trials Browser

Enrolling by invitation × INDUSTRY × Myasthenia Gravis × Clear all

NCT06435312 2026-03-13

ziMyG+

Phase 3 Enrolling by invitation

Myasthenia Gravis

NCT06540144 2026-02-27

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Phase 3 Enrolling by invitation

Myasthenia Gravis

NCT05374590 2026-02-02

ADAPT Jr +

Phase 2/3 Enrolling by invitation

Myasthenia Gravis